- Home
- AIRS vs NKTR Comparison
AIRS vs NKTR Comparison
Compare AIRS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- NKTR
- Stock Information
- Founded
- AIRS 2012
- NKTR 1990
- Country
- AIRS United States
- NKTR United States
- Employees
- AIRS N/A
- NKTR N/A
- Industry
- AIRS Medical/Nursing Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- AIRS Health Care
- NKTR Health Care
- Exchange
- AIRS Nasdaq
- NKTR Nasdaq
- Market Cap
- AIRS 166.3M
- NKTR 108.3M
- IPO Year
- AIRS 2021
- NKTR 1994
- Fundamental
- Price
- AIRS $5.25
- NKTR $24.31
- Analyst Decision
- AIRS Hold
- NKTR Strong Buy
- Analyst Count
- AIRS 3
- NKTR 6
- Target Price
- AIRS $3.75
- NKTR $77.50
- AVG Volume (30 Days)
- AIRS 736.1K
- NKTR 4.4M
- Earning Date
- AIRS 08-08-2025
- NKTR 08-07-2025
- Dividend Yield
- AIRS N/A
- NKTR N/A
- EPS Growth
- AIRS N/A
- NKTR N/A
- EPS
- AIRS N/A
- NKTR N/A
- Revenue
- AIRS $172,101,000.00
- NKTR $87,248,000.00
- Revenue This Year
- AIRS N/A
- NKTR N/A
- Revenue Next Year
- AIRS $4.90
- NKTR N/A
- P/E Ratio
- AIRS N/A
- NKTR N/A
- Revenue Growth
- AIRS N/A
- NKTR N/A
- 52 Week Low
- AIRS $1.53
- NKTR $6.48
- 52 Week High
- AIRS $9.20
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- AIRS 58.50
- NKTR 68.55
- Support Level
- AIRS $4.65
- NKTR $8.27
- Resistance Level
- AIRS $5.13
- NKTR $37.38
- Average True Range (ATR)
- AIRS 0.40
- NKTR 3.54
- MACD
- AIRS -0.08
- NKTR 1.72
- Stochastic Oscillator
- AIRS 52.88
- NKTR 55.75
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.